title: Emerging pathogen in immunocompromised hosts: Exophiala dermatitidis mycosis in graft-versus-host disease.
abstract: Infection with the dematiaceous environmental fungus Exophiala, an emerging pathogen in immunocompromised individuals, poses a diagnostic and therapeutic challenge. Herein, we report the first Exophiala dermatitidis fungemia case, to our knowledge, in an allogeneic hematopoietic stem cell transplant patient with graft-versus-host disease, expanding the clinical setting where Exophiala species mycosis should be suspected.
authors.affiliation: Division of Infectious Diseases, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA.
authors.forename: S
authors.initials: S
authors.lastname: Chalkias
authors.forename: C D
authors.initials: CD
authors.lastname: Alonso
authors.forename: J D
authors.initials: JD
authors.lastname: Levine
authors.forename: M T
authors.initials: MT
authors.lastname: Wong
mesh_terms: D000935:Antifungal Agents / Q000008:administration & dosage / Q000627:therapeutic use; D021821:Communicable Diseases, Emerging / Q000382:microbiology*; D025141:Drug Resistance, Fungal; D005093:Exophiala / Q000187:drug effects / Q000302:isolation & purification*; D006086:Graft vs Host Disease / Q000150:complications*; D018380:Hematopoietic Stem Cell Transplantation / Q000009:adverse effects*; D006801:Humans; D020522:Lymphoma, Mantle-Cell / Q000628:therapy; D008297:Male; D008875:Middle Aged; D009894:Opportunistic Infections; D060446:Phaeohyphomycosis / Q000188:drug therapy* / Q000382:microbiology*
chemical_list: D000935:Antifungal Agents
keywords: Exophiala; graft-versus-host disease; hematopoietic stem cell transplant